Physical Therapists Identifying Patients With Opioid Misuse

Sponsor
University of Utah (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05497154
Collaborator
(none)
12
1
10

Study Details

Study Description

Brief Summary

The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have opioid misuse (OM). The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Training Arm
N/A

Detailed Description

The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have OM. The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures. Approximately 4 months following the development of the manual and the distribution of the finalized manual, the investigators will conduct semi-structured interviews to determine the barriers and facilitators to implementing the procedures learned in the training.

Our aims are:
  1. Qualitatively evaluate physical therapists' perceptions and recommendations for implementing OM procedures.

  2. Evaluate the implementation of the manualized OM procedures.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Physical Therapists Identifying Patients With Opioid Misuse
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
May 31, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training Arm

Behavioral: Training Arm
The training will be composed of 4 separate training sessions provided every 2 - 4 weeks. During the 1st session (45 minutes), the investigators will educate the physical therapist about the different categories of opioid use including opioid misuse (OM) and the risks associated with OM as well as training to engage the patient in a conversation about opioid use. The 2nd and 3rd sessions (30 minutes each) involve training in procedures to screen and assess patients at risk for OM, respectively. The 4th session (30 minutes) involves training in procedures to refer patients to a specialist or a primary care provider for further treatment if OM is suspected.

Outcome Measures

Primary Outcome Measures

  1. Change in the Drug and Drug Problems Perception Questionnaire (DDPPQ) [Baseline, immediate post training, 4 months after last training session]

    The DDPPQ is a 20 item tool used to measure the attitudes of health care providers related to the management of patients misusing drugs and contains 5 subscales (Role Adequacy: 7 items; Role Legitimacy: 2 items; Role Support: 3 items; Role Self-esteem: 4 items; Job Satisfaction: 4 items) Each item is scored on a 7-point scale (1 = strongly agree to 7 = strongly disagree). Each item was modified to asses the health care providers' attitudes about managing patients with opioid missue.

Other Outcome Measures

  1. Thematic analysis from semi-structured interviews [4 months after the last training session]

    Semi-structured interviews to assess barriers and facilitators of implementing the procedures learned in the training

  2. Reach [Immediate post training]

    Proportion of physical therapists who agreed to attend the training that attended all training sessions

  3. Adoption 1- engaging patients in conversations [Approximately 4 months after last training session]

    Percentage of physical therapists who attended the training that report engaging patients in conversations about opioid misuse,

  4. Adoption 2 - screening [Approximately 4 months after last training session]

    Percentage of physical therapists who attended the training that report screening for opioid misuse

  5. Adoption 3 - assessing [Approximately 4 months after last training session]

    Percentage of physical therapists who attended the training that report assessing patients for opioid misuse

  6. Adoption 4 - referring [Approximately 4 months after last training session]

    Percentage of physical therapists who attended the training that report referring for opioid misuse

  7. Thematic analysis of focus groups [Approximately 1 month after last training session]

    The investogators will conduct focus groups after each training session to assess the physical therapists' receptivity to the procedures learned in the training.

  8. Change in the Frequency of opioid misuse management practices - Adapted from the Alcohol Education Survey [Baseline, immediately post training and to approximately 4 months after the last training session]

    Questions were adapted: "How often do you ask patients about alcohol problems?" was modified to: "How often do you ask patients about problems with prescription opioid medication misuse? 4 additional questions were similarly modified ([1] How often do you formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [2] How often do you assess patients' readiness to change their prescription opioid medication misuse behaviors?; [3] How often do you discuss/advise patients to change their prescription opioid medication misuse behaviors?; [4] How often do you refer patients with prescription opioid medication misuse for further assessments or interventions?). Scoring: Never, Rarely (less than 10% of the time), Occasionally (about 30% of the time), Sometimes (about 50% of the time), Frequently (about 70% of the time), Usually (about 90% of the time), Every time.

  9. Manual of procedures [Approximately 4 months after the last training session.]

    At the end of the study after the individual interviews, the investigators will finalize the manual of opioid misuse procedures for physical therapists.

  10. Change in the Confidence in opioid misuse management practices. Adapted from the Alcohol Education Survey [Baseline, immediately post training and to approximately 4 months after the last training session]

    These questions were adapted from a survey developed to improve health care providers' management of patients with alcohol problems. The questions are: ([1] I am confident in my ability to ask patients about prescription opioid medication misuse, [2] I am confident in my ability to formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [3] I am confident in my ability to assess patients' readiness to change their prescription opioid medication misuse behaviors; [4] I am confident in my ability to discuss/advise patients to change their prescription opioid medication misuse behaviors; [5] I am confident in my ability to refer patients with prescription opioid medication misuse for further assessments or interventions?). Each confidence with management practice question was scored on a 7-point Likert scale (1 = no confidence; 7 = high confidence).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • University of Utah physical therapists with at least 0.5 full-time equivalent

  • Self report managing patients with musculoskeletal pain

Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Utah

Investigators

  • Principal Investigator: John Magel, PhD, University of Utah

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jake Magel, Research Associate Professor, University of Utah
ClinicalTrials.gov Identifier:
NCT05497154
Other Study ID Numbers:
  • 3394
First Posted:
Aug 11, 2022
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jake Magel, Research Associate Professor, University of Utah
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 11, 2022